dr. horn discusses next steps with atezolizumab in sclc
Published 6 years ago • 409 plays • Length 1:12Download video MP4
Download video MP3
Similar videos
-
1:08
dr. horn on the fda approval of atezolizumab plus bevacizumab and chemotherapy in nsclc
-
1:22
dr. horn on updated data from impower133 in small cell lung cancer
-
1:07
dr. nanus on next steps with atezolizumab in patients with muc
-
1:50
dr. melissa johnson on atezolizumab in patients with nsclc
-
0:51
dr. leora horn on toxicities with immunotherapy in lung cancer
-
4:00
atezolizumab plus chemotherapy in extensive-stage small cell lung cancer
-
1:15
dr. rudin discusses the success of immunotherapy in sclc
-
1:07
dr. horn on the role of mobocertinib in nsclc
-
1:27
fda approval of atezolizumab for nsclc
-
1:51
dr. horn on selecting inhibitors for alk nsclc
-
1:34
dr. horn on monitoring response and resistance to ensartinib in alk nsclc
-
6:33
a win for small–cell lung cancer: impower 133
-
1:41
dr. atkins on results of atezolizumab plus bevacizumab in rcc
-
14:00
asco 2021 lung recap: impower010: atezolizumab after chemo in non-small cell lung cancer
-
0:34
alexander spira, md, phd, facp, on the recent approval of atezolizumab in sclc
-
1:03
sangeetha palakurthi on fda approval of atezolizumab in nsclc
-
2:12
real-world study of atezolizumab vs. pembrolizumab for advanced/metastatic uc
-
2:08
dr. borghaei on second-line therapy in sclc
-
1:05
dr. sabari discusses role of immunotherapy in sclc